ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,435, issued on Sept. 9, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.), Massachusetts Institute of Technology (Cambridge, Mass.) and UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa).
"Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders" was invented by Beverly Davidson (Iowa City, Iowa), Chie-Yu Lin (Cambridge, Mass.), Edgardo Rodriguez (Iowa City, Iowa) and Feng Zhang (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides for delivery, engineering and optimization of systems, methods, and compositions for manipulation of sequences and/or activities of target seq...